Molecule Details
InChIKeyVHGCDTVCOLNTBX-QGZVFWFLSA-N
Compound NameAtomoxetine
Canonical SMILESCNCC[C@@H](Oc1ccccc1C)c1ccccc1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)2
Pfam Stratification Homologous
Avg pChEMBL7.53
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB00289
Drug NameAtomoxetine
CAS Number83015-26-3
Groups approved investigational
ATC Codes N06BA09
DescriptionAtomoxetine is a selective norepinephrine (NE) reuptake inhibitor used for the treatment of attention deficit hyperactivity disorder (ADHD). Also known as the marketed product Strattera, atomoxetine is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc...

Categories: Adrenergic Agents Agents producing tachycardia Agents that produce hypertension Amines Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP2D6 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Drugs that are Mainly Renally Excreted Membrane Transport Modulators Miscellaneous Central Nervous System Agents Nervous System Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Norepinephrine Reuptake Inhibitor Norepinephrine Uptake Inhibitors Potential QTc-Prolonging Agents Propylamines Psychostimulants, Agents Used for ADHD and Nootropics QTc Prolonging Agents
Cross-references: BindingDB: 50366567 ChEBI: 127342 CHEMBL641 ChemSpider: 49516 Drugs Product Database (DPD): 13584 D07473 PDB: A1LX4 PharmGKB: PA134688071 PubChem:54841 PubChem:46506160 RxCUI: 38400 Therapeutic Targets Database: DAP000721 Wikipedia: Atomoxetine ZINC: ZINC000001842633
Target Activities (2)
Target Gene Organism Category Pfam pChEMBL Type Source
P23975 SLC6A2 Homo sapiens Human PF00209 8.3 IC50 ChEMBL;BindingDB
P31645 SLC6A4 Homo sapiens Human PF03491 PF00209 6.8 IC50 ChEMBL;BindingDB
DrugBank Target Actions (10)
Target Gene Target Name Action Type
P02763 P02763 alpha1-acid glycoprotein binder carriers
P02768 ALB Albumin binder carriers
P12314 P12314 High affinity immunoglobulin gamma Fc receptor I binder carriers
P10635 CYP2D6 Cytochrome P450 2D6 substrate enzymes
P33261 CYP2C19 Cytochrome P450 2C19 substrate enzymes
Q05586 GRIN1 NMDA receptor blocker targets
P23975 SLC6A2 Sodium-dependent noradrenaline transporter inhibitor targets
P31645 SLC6A4 Sodium-dependent serotonin transporter inhibitor targets
P48549 KCNJ3 G protein-activated inward rectifier potassium channel 1 inhibitor targets
P41145 OPRK1 Kappa-type opioid receptor partial agonist targets